Cyclopharm Limited Appendix 4D - Half Year Report For the half year ended 30 June 2026 To: COMPANY ANNOUNCEMENTS Company: Australian Securities Exchange No of Pages: 42 incl. cover Date: 24 August 2026 From: James McBrayer Subject: Appendix 4D and...
Cyclopharm: Half Yearly Report and Accounts
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Cyclopharm
- New US Lung Imaging Guidelines Name Technegas as Preferred A
- ausbiz TV Presentation
- Immediate 11-Site Technegas Rollout at University Hospitals
- CYC First-Half 2026 Update
- USA Technegas Expansion Update
Later from Cyclopharm
- CYC 1H2026 Results Summary
- Cyclopharm 1H 2026 Results Webinar
- Chinese Consensus Names Technegas Preferred Lung Agent
- Change in substantial shareholding for CYC
- Retirement of Non-Executive Director Dianne Angus
Follow Cyclopharm into a list and get an email when it puts out news.
Follow Cyclopharm